Rodrigo Alarcón

1.1k total citations
13 papers, 948 citations indexed

About

Rodrigo Alarcón is a scholar working on Physiology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Rodrigo Alarcón has authored 13 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Pharmacology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Rodrigo Alarcón's work include Alzheimer's disease research and treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Computational Drug Discovery Methods (5 papers). Rodrigo Alarcón is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Computational Drug Discovery Methods (5 papers). Rodrigo Alarcón collaborates with scholars based in Chile, United States and Canada. Rodrigo Alarcón's co-authors include Alejandra Álvarez, Carlos Opazo, Rommy von Bernhardi, Jorge Garrido, Nibaldo C. Inestrosa, Carolina Fuenzalida, Gigliola Ramírez, Eliseo O. Campos, Alejandro D. Roth and Francisco J. Muñoz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Rodrigo Alarcón

11 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodrigo Alarcón Chile 9 545 476 309 272 171 13 948
María‐Salud García‐Ayllón Spain 21 506 0.9× 536 1.1× 238 0.8× 472 1.7× 119 0.7× 48 1.4k
Margarita C. Dinamarca Chile 16 562 1.0× 595 1.3× 302 1.0× 528 1.9× 134 0.8× 19 1.3k
Dawid Panek Poland 16 703 1.3× 445 0.9× 480 1.6× 344 1.3× 81 0.5× 24 1.2k
Jakub Jończyk Poland 17 576 1.1× 336 0.7× 414 1.3× 373 1.4× 69 0.4× 41 1.1k
Francisco J. Carvajal Chile 13 239 0.4× 347 0.7× 107 0.3× 364 1.3× 114 0.7× 19 876
Shengquan Hu Hong Kong 21 310 0.6× 307 0.6× 89 0.3× 388 1.4× 136 0.8× 40 1.0k
Diana F. Silva Portugal 19 209 0.4× 465 1.0× 107 0.3× 523 1.9× 158 0.9× 28 1.2k
Zhao-Feng Jiang China 22 248 0.5× 750 1.6× 85 0.3× 544 2.0× 153 0.9× 31 1.4k
Inna Khlistunova Germany 10 388 0.7× 980 2.1× 236 0.8× 478 1.8× 195 1.1× 12 1.3k
Tatsuhiro Akaishi Japan 16 275 0.5× 346 0.7× 56 0.2× 314 1.2× 161 0.9× 26 1.0k

Countries citing papers authored by Rodrigo Alarcón

Since Specialization
Citations

This map shows the geographic impact of Rodrigo Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Alarcón more than expected).

Fields of papers citing papers by Rodrigo Alarcón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodrigo Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Alarcón. The network helps show where Rodrigo Alarcón may publish in the future.

Co-authorship network of co-authors of Rodrigo Alarcón

This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Alarcón. A scholar is included among the top collaborators of Rodrigo Alarcón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Alarcón. Rodrigo Alarcón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Alarcón, Rodrigo, et al.. (2019). Histeropexia vs histerectomía para el tratamiento quirúrgico del prolapso genital: revisión sistemática. ARS MEDICA Revista de Ciencias Médicas. 44(3). 54–61.
3.
Alarcón, Rodrigo, et al.. (2018). Evaluación por médicos especialistas de curso de urgencias gineco-obstétricas utilizando metodología de simulación clínica. SHILAP Revista de lepidopterología. 43(1). 25–29.
4.
Alarcón, Rodrigo, et al.. (2005). Expression of Scavenger Receptors in Glial Cells. Journal of Biological Chemistry. 280(34). 30406–30415. 134 indexed citations
5.
Roth, Alejandro D., Gigliola Ramírez, Rodrigo Alarcón, & Rommy von Bernhardi. (2005). Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation. Biological Research. 38(4). 381–7. 107 indexed citations
6.
Bernhardi, Rommy von, Rodrigo Alarcón, Diego Mezzano, Patricio Fuentes, & Nibaldo C. Inestrosa. (2005). Blood Cells Cholinesterase Activity in Early Stage Alzheimer’s Disease and Vascular Dementia. Dementia and Geriatric Cognitive Disorders. 19(4). 204–212. 29 indexed citations
7.
Valenzuela, Alfonso, Rommy von Bernhardi, Gigliola Ramírez, et al.. (2003). Supplementation of Female Rats with α-Linolenic Acid or Docosahexaenoic Acid Leads to the Same Omega-6/Omega-3 LC-PUFA Accretion in Mother Tissues and in Fetal and Newborn Brains. Annals of Nutrition and Metabolism. 48(1). 28–35. 27 indexed citations
8.
Inestrosa, Nibaldo C. & Rodrigo Alarcón. (1998). Molecular interactions of acetylcholinesterase with senile plaques. Journal of Physiology-Paris. 92(5-6). 341–344. 53 indexed citations
9.
Pérez, Daniel R., Rodrigo Alarcón, & Nibaldo C. Inestrosa. (1998). Kinetic and thermodynamic effects of acetylcholinesterase on the solubility of Aβ peptide. Journal of Physiology-Paris. 92(5-6). 479–479. 1 indexed citations
10.
Álvarez, Alejandra, Rodrigo Alarcón, Carlos Opazo, et al.. (1998). Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils. Journal of Neuroscience. 18(9). 3213–3223. 278 indexed citations
11.
Álvarez, Alejandra, et al.. (1997). Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils 1 1Edited by A. R. Fersht. Journal of Molecular Biology. 272(3). 348–361. 264 indexed citations
12.
Inestrosa, Nibaldo C., et al.. (1994). Blood markers in Alzheimer disease: Subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes. Journal of the Neurological Sciences. 122(1). 1–5. 35 indexed citations
13.
Inestrosa, N. C., et al.. (1993). Platelet of Alzheimer patients: Increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine. Neuroscience Letters. 163(1). 8–10. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María‐Salud García‐Ayllón Breakdown of academic impact, for papers by Margarita C. Dinamarca Breakdown of academic impact, for papers by Dawid Panek Breakdown of academic impact, for papers by Jakub Jończyk Breakdown of academic impact, for papers by Francisco J. Carvajal Breakdown of academic impact, for papers by Shengquan Hu Breakdown of academic impact, for papers by Diana F. Silva Breakdown of academic impact, for papers by Zhao-Feng Jiang Breakdown of academic impact, for papers by Inna Khlistunova Breakdown of academic impact, for papers by Tatsuhiro Akaishi
Rankless by CCL
2026